Abstract 39: Risk Factor Contributions Toward Incident Cardiovascular Disease Among Younger Adults With Short- and Long-Term Predicting Risk of Cardiovascular Disease EVENTs (PREVENT) Risk: The Reasons for Geographic and Racial Differences in Stroke (REGARDS) Cohort

M Mohan Satish (New York Presbyterian - Weill Cornell Medical Center, New York, New York, United States) J joanna Ringel (Weill Cornell Medicine, New York, New York, United States) G Ghislaine Jumonville (Weill Cornell Medicine, New York, New York, United States) H Hugo G Quezada-Pinedo (Duke University, Durham, North Carolina, United States) R Ryan Walters (Creighton University, Omaha, Nebraska, United States) V Vinay Kini (Weill Cornell Medicine, New York, New York, United States) S Shakia Hardy (Univ of North Carolina Chapel Hill, Mebane, North Carolina, United States) P Paul Muntner (Perisphere real world evidence, Austin, Texas, United States) E Emily Levitan (UNIVERSITY ALABAMA AT BIRMINGHAM, Birmingham, Alabama, United States) M Monika Safford (WEILL CORNELL MEDICINE, New York, New York, United States) L Lisandro Colantonio (UNIVERSITY OF ALABAMA AT BIRMINGHAM, Birmingham, Alabama, United States)

Abstract

Background: The American Heart Association’s PREVENT risk equations estimate both 10-year and 30-year risks for cardiovascular disease (CVD) in younger adults aged 30–59 years. Recent analyses show that many younger adults have low short-term (10-year) risk but high long-term (30-year) predicted CVD risk. However, it is unclear which risk factors can be prioritized for the largest population benefit to mitigate long-term CVD risk within this PREVENT risk strata. Objective: We quantified the contribution of risk factors for incident CVD in younger adults classified as having low short-term risk but high long-term risk by PREVENT within the national REGARDS prospective cohort. Methodology: We included participants 45-59 years of age in the REGARDS cohort without prevalent atherosclerotic CVD (ASCVD) or heart failure (HF) recruited in 2003-07 from the continental United States. We estimated the sex-specific prevalence, age and race adjusted hazard ratios accounting for competing risk of non-CVD death, and the population attributable risk percent (PAR%) for incident CVD associated with hypertension, dyslipidemia, obesity, diabetes, current smoking, chronic kidney disease [CKD], high-sensitivity C-reactive protein (hs-CRP) ≥ 3 mg/dL, and a family history of ASCVD. The prevalence and PAR% were calculated for the low 10-year (< 12.5%)/high 30-year (≥30%) risk group of interest by PREVENT, and stratified by sex. A low 10-year total CVD risk threshold (<12.5%) was defined by a risk percentile method consistent with a low 10-year ASCVD risk (<7.5%). Results: Among 6,761 participants, 1,421 (21.0%) had low 10-year/high 30-year PREVENT risk (703 women and 718 men). Overall, there were 566 incident CVD events over a median follow-up of 14.4 years, of which there 194 incident CVD events occurred in the low 10-year/high 30-year PREVENT risk group. Within the low 10-year/high 30-year PREVENT risk group, the highest PAR% for incident CVD were for hypertension (65%), diabetes (45%), and obesity (35%) in women, in comparison to hypertension (40%), hs-CRP ≥ 3 mg/dL (26%), and dyslipidemia (25%) in men (Table 1). Conclusion: Hypertension is the largest contributor to incident CVD among younger adults with low short-term but high-long term predicted CVD risk, and supports the role of early primary prevention strategies focusing on treating hypertension in this population.

Article Details

Journal Circulation
Volume / Issue Vol. 153, Issue Suppl_1
Published March 24, 2026
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (11)

M

Mohan Satish

New York Presbyterian - Weill Cornell Medical Center, New York, New York, United States

J

joanna Ringel

Weill Cornell Medicine, New York, New York, United States

G

Ghislaine Jumonville

Weill Cornell Medicine, New York, New York, United States

H

Hugo G Quezada-Pinedo

Duke University, Durham, North Carolina, United States

R

Ryan Walters

Creighton University, Omaha, Nebraska, United States

V

Vinay Kini

Weill Cornell Medicine, New York, New York, United States

S

Shakia Hardy

Univ of North Carolina Chapel Hill, Mebane, North Carolina, United States

P

Paul Muntner

Perisphere real world evidence, Austin, Texas, United States

E

Emily Levitan

UNIVERSITY ALABAMA AT BIRMINGHAM, Birmingham, Alabama, United States

M

Monika Safford

WEILL CORNELL MEDICINE, New York, New York, United States

L

Lisandro Colantonio

UNIVERSITY OF ALABAMA AT BIRMINGHAM, Birmingham, Alabama, United States